Several studies have shed light on the role of LHPP in inhibiting tumor growth via repression of AKT activation, evidenced in various cancers such as hepatocellular carcinoma [8], nasopharyngeal carcinoma [34], oral squamous cell carcinoma [10], and notably prostate cancer [6]. This evidence concerns the gene AKT1 and prostate cancer.